These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20832909)

  • 41. Recommendations for the therapeutics of methotrexate in rheumatoid arthritis.
    Murphy G; Coughlan R; Devlin J; FitzGerald O; McCarthy G
    Ir Med J; 2009 Jun; 102(6):170-2. PubMed ID: 19722351
    [No Abstract]   [Full Text] [Related]  

  • 42. Nodulosis during methotrexate therapy for rheumatoid arthritis.
    Das SK; Kumar A
    J Assoc Physicians India; 1995 Sep; 43(9):651. PubMed ID: 8773077
    [No Abstract]   [Full Text] [Related]  

  • 43. Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.
    Ornetti P; Solau E; Gaudin P; Sibilia J; Berthelot JM; Puechal X; Tavernier C; Maillefert JF;
    Ann Rheum Dis; 2005 Sep; 64(9):1379-80. PubMed ID: 16100349
    [No Abstract]   [Full Text] [Related]  

  • 44. A weekly dosage taken daily.
    Karch AM; Karch FE
    Am J Nurs; 2003 Apr; 103(4):64. PubMed ID: 12677124
    [No Abstract]   [Full Text] [Related]  

  • 45. Fatal outcome of an Epstein-Barr virus positive mucocutaneous ulcer secondary to methotrexate.
    Nakauyaca A; Kalro A; Donaldson E; Patel H
    Intern Med J; 2016 Oct; 46(10):1226-1228. PubMed ID: 27734625
    [No Abstract]   [Full Text] [Related]  

  • 46. Methotrexate and bone marrow suppression: drug errors may be implicated in death.
    Grove ML
    BMJ; 2003 May; 326(7399):1145; author reply 1145-6. PubMed ID: 12764001
    [No Abstract]   [Full Text] [Related]  

  • 47. [Methotrexate-related deaths in patients with rheumatoid arthritis].
    Sinicina I
    MMW Fortschr Med; 2011 Oct; 153(40):42-3, 45. PubMed ID: 22069900
    [No Abstract]   [Full Text] [Related]  

  • 48. [Can a combination therapy with leflunomide be recommended for patients with active rheumatoid arthritis?].
    Hamann F
    Z Rheumatol; 2003 Apr; 62(2):204-5. PubMed ID: 12820624
    [No Abstract]   [Full Text] [Related]  

  • 49. Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination.
    Toth P; Bernd R
    Rev Bras Reumatol; 2014; 54(2):152-4. PubMed ID: 24878863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Drug therapy and malpractice exemplified by combination leflunomide and methotrexate therapy].
    Burgardt C
    Z Rheumatol; 2002 Apr; 61(2):189-90. PubMed ID: 12056298
    [No Abstract]   [Full Text] [Related]  

  • 51. Successful desensitization to low-dose methotrexate.
    Fernando SL
    Rheumatology (Oxford); 2013 Dec; 52(12):2305-6. PubMed ID: 23681395
    [No Abstract]   [Full Text] [Related]  

  • 52. [Ulcerative stomatitis as clinical clue to inadvertent methotrexate overdose].
    Bauer J; Fartasch M; Schuler G; Schell H
    Hautarzt; 1999 Sep; 50(9):670-3. PubMed ID: 10501685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term combination therapy of chronic polyarthritis: methotrexate and parenteral gold].
    Krause D
    Z Rheumatol; 1998 Feb; 57(1):37-40. PubMed ID: 9566106
    [No Abstract]   [Full Text] [Related]  

  • 54. [Leflunomide + methotrexate combination therapy from the physician's viewpoint].
    Reinhold-Keller E; Gromnica-Ihle E
    Z Rheumatol; 2002 Apr; 61(2):191-3. PubMed ID: 12056299
    [No Abstract]   [Full Text] [Related]  

  • 55. Methotrexate-induced pancytopenia associated with co-prescription of penicillin and trimethoprim.
    Sathi N; Dawson J
    Clin Rheumatol; 2007 Jan; 26(1):134-5. PubMed ID: 16941195
    [No Abstract]   [Full Text] [Related]  

  • 56. [Methotrexate in rheumatology: a therapeutic revolution].
    Kaye O; Ribbens C; Hauwaert C; Malaise MG
    Rev Med Liege; 1995 Nov; 50(11):453-7. PubMed ID: 8532990
    [No Abstract]   [Full Text] [Related]  

  • 57. [Methotrexate pneumonitis].
    Zingg K; Grossenbacher M; Conen D; Truninger K
    Praxis (Bern 1994); 1999 Mar; 88(13):573-8. PubMed ID: 10235032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safe prescribing of methotrexate for rheumatoid arthritis.
    Kirkham BW
    Med J Aust; 1995 Sep; 163(5):278. PubMed ID: 7565224
    [No Abstract]   [Full Text] [Related]  

  • 59. The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis.
    Sakai R; Komano Y; Tanaka M; Nanki T; Koike R; Nakajima A; Atsumi T; Yasuda S; Tanaka Y; Saito K; Tohma S; Fujii T; Ihata A; Tamura N; Kawakami A; Sugihara T; Ito S; Miyasaka N; Harigai M
    Mod Rheumatol; 2011 Aug; 21(4):444-8. PubMed ID: 21312050
    [No Abstract]   [Full Text] [Related]  

  • 60. Cytomegalovirus-induced pneumonia in a rheumatoid arthritis patient treated with low dose methotrexate.
    Thomas E; Olive P; Mazyad H; Blotman F
    Clin Exp Rheumatol; 1997; 15(5):583-4. PubMed ID: 9307872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.